Biological Variation in Tests of Hemostasis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0028-1104541PMID 19085763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological Variation in Tests of Hemostasis

  2009cited by this paper
• Meta-Analysis Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies

  2007cited by this paper
• Diagnostic approach to inherited bleeding disorders

  2007cited by this paper
• Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.

  2007cited by this paper
• Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability

  2007cited by this paper
• Genetic influences on fibrinogen, tissue plasminogen activatorantigen and von Willebrand factor in males and females

  2006cited by this paper
• Pre‐analytical factors and measurement uncertainty

  2005cited by this paper
• Analytical goals for coagulation tests based on biological variation

  2004cited by this paper
• Inherent biological variation and reference values

  2004cited by this paper
• Associations of haemostatic variables with body mass index: a community-based study

  2003cited by this paper
• Parameters of coagulant and fibrinolytic capacity and activity in postmenopausal women: within-subject variability.

  2002cited by this paper
• Influence of the ABO Blood Type on the Platelet Function Analyzer PFA-100

  2001cited by this paper
• Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology.

  1999cited by this paper
• Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.

  1999cited by this paper
• Current databases on biological variation: pros, cons and progress.

  1999cited by this paper
• Sex Differences in the Determinants of Fibrinolytic Activity

  1998cited by this paper
• Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort

  1998cited by this paper
• Intra- and Interindividual Variability of Hemostatic Factors and Traditional Cardiovascular Risk Factors in a Three-year Follow-up

  1998cited by this paper
• Intra- and inter-individual biological variability data bank.

  1997cited by this paper
• Variation in Plasma Fibrinogen over One Year: Relationships with Genetic Polymorphisms and Non-genetic Factors

  1997cited by this paper
• The VITA Project: Population-based Distributions of Protein C, Antithrombin III, Heparin-cofactor II and Plasminogen -Relationship with Physiological Variables and Establishment of Reference Ranges

  1996cited by this paper
• Technical and Biological Conditions Influencing the Functional APC Resitance Test

  1996cited by this paper
• Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

  1996cited by this paper
• International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements.

  1995cited by this paper
• Components of biological, including seasonal, variation in hematological measurements and plasma fibrinogen concentrations in normal humans

  1995cited by this paper
• ARIC Hemostasis Study-IV. Intraindividual Variability and Reliability of Hemostatic Factors

  1995cited by this paper
• Protein C, antithrombin III and plasminogen: effect of age, sex and blood group

  1994cited by this paper
• Protein C Activity in Healthy Volunteers - Influence of Age, Sex, Smoking and Oral Contraceptives

  1993cited by this paper
• Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis

  1993cited by this paper
• Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin.

  1993influential reference
• Within-Subject and Between-Subject Biological Variation of Prothrombin Time and Activated Partial Thromboplastin Time

  1992cited by this paper
• Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study.

  1992cited by this paper
• The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids.

  1992cited by this paper
• Morning hypercoagulability in man

  1990cited by this paper
• Circadian variations in platelet functions and blood coagulation parameters

  1990influential reference
• Biologic variation of common hematologic laboratory quantities in the elderly.

  1989cited by this paper
• Daytime Fluctuations in Blood of Tissue-Type Plasminogen Activator (t-PA) and Its Fast-Acting Inhibitor (PAI-1)

  1988cited by this paper
• Sources of Variability in Coagulation Factor Assays

  1987cited by this paper
• Circulating Activities During Constant Infusion of Heparin or a Low Molecular Weight Derivative (Enoxaparine): Failure to Demonstrate any Circadian Variations

  1987cited by this paper
• Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.

  1987cited by this paper
• Short-Term and Long-Term Intra-Individual Variations and Critical Differences of Coagulation Parameters

  1985cited by this paper
• Short-Term and Long-Term Intra-Individual Variations and Critical Differences of Haematological Laboratory Parameters

  1985cited by this paper
• Relationship of air temperature to various chemical, haematological, and haemostatic variables.

  1979cited by this paper

• The impact of pathological fluctuations versus biological variation on the interpretation of laboratory values

  2025cites this paper
• Measurement Uncertainty in the Hemostasis Laboratory

  2025cites this paper
• FRONTIER1 multiple ascending dose extension: a safety, tolerability, pharmacokinetics, and pharmacodynamics study of Mim8 in people with hemophilia A

  2025cites this paper
• The Acute Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers: A Randomized Trial.

  2024cites this paper
• Comparison of ADAMTS13 and Von Willebrand factor levels and activities, and plasminogen levels, in plasma products currently available for the treatment of thrombotic thrombocytopenic purpura in South Africa.

  2019cites this paper
• Reduction of the turn‐around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

  2018cites this paper
• Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women

  2018cites this paper
• Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individuals

  2018cites this paper
• Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications.

  2016cites this paper
• Utilisation of Quartz Crystal Microbalance Sensors with Dissipation (QCM-D) for a Clauss Fibrinogen Assay in Comparison with Common Coagulation Reference Methods

  2016cites this paper
• Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).

  2014cites this paper
• Mesure de la génération de thrombine et son application pour la surveillance pharmacothérapeutique de l'héparine de faible poids moléculaire chez le chien

  2014cites this paper
• Comparison of components of biological variation between 3 equine thromboelastography assays.

  2013cites this paper
• Local and Systemic Expressions of MMP-9, TIMP-1 and PAI-1 in Patients Undergoing Surgery for Clinically Suspected Appendicitis

  2012cites this paper
• Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis

  2012cites this paper
• Doping and Thrombosis in Sports

  2011cites this paper
• Biological Variation in Tests of Hemostasis

  2009cites this paper